Clinical Trials Browser

Neoadjuvant Therapy × 1 year × Clear all

NCT07054242 2025-10-01

A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)

Phase 2 Not yet recruiting

Neoadjuvant Therapy

NCT06734702 2025-07-24

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 3 Recruiting

Neoadjuvant Therapy